/
MULTICENTRIC T-CELL RICH B-CELL LYMPHOMA IN A MULE MULTICENTRIC T-CELL RICH B-CELL LYMPHOMA IN A MULE

MULTICENTRIC T-CELL RICH B-CELL LYMPHOMA IN A MULE - PowerPoint Presentation

valerie
valerie . @valerie
Follow
343 views
Uploaded On 2022-06-14

MULTICENTRIC T-CELL RICH B-CELL LYMPHOMA IN A MULE - PPT Presentation

Jarrod Troy ISUCVM Class of 2014 416 Billy Sunday Rd Apt 101 Ames IA 50010 Mentor Stephanie Caston DVM DACVSLA Iowa State University Equine Surgery Service Case Previously Presented by R David Whitley DVM MS DACVO ID: 917567

bilateral cell dvm cells cell bilateral cells dvm eyelid lymphoma positive equine results lymphocytes clinical palpebral conjunctival ocular pouch

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "MULTICENTRIC T-CELL RICH B-CELL LYMPHOMA..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

MULTICENTRICT-CELL RICH B-CELL LYMPHOMA IN A MULE

Jarrod Troy ISU-CVM Class of 2014416 Billy Sunday Rd Apt. 101Ames IA 50010Mentor: Stephanie Caston, DVM, DACVS-LAIowa State University Equine Surgery Service

Case Previously Presented by R David Whitley, DVM, MS, DACVO

International

Equine Ophthalmic Consortium

West

Palm Beach, FL

April 2011

 BILATERAL THIRD EYELID LYMPHOMA IN A MULE

Whitley EM, Murphy M, Haynes JS, Caston S, Madron M, Waller KR, Tofflemire K, Whitley

RD

Slide2

SIGNALMENT

“Hank”25 year old castrated Mule495-kg (1090-lb) Presented at Iowa State University Equine Surgery Service for bilateral surgical removal of third eyelids

Slide3

HISTORY

12/14/10: 6 week duration of progressive bilateral third eyelid swelling.

Slide4

INITIAL CLINICAL FINDINGS

Bilateral bulbar and palpebral conjunctival thickeningThird eyelid protrusionMild bilateral exophthalmosPatent nasolacrimal ducts Mild ocular discharge

ParameterHank’s ValueReference IntervalTemperature (F

0/C0)98.7/37.1

99.0-100.8

/37.2-38.1

Heart Rate (beats/minute)

32

28-40

Respiratory Rate (breaths/minute)

24

10-14

Slide5

DIAGNOSTIC PLAN

Skull RadiographsDorsoventral & Lateral Oblique Views Collimated to Mid-Skull; Oblique Views Collimated to OrbitsFindingsBilateral exophthalmosHeterogeneous soft tissue masses (~7cm) rostroventral to globesGuttural pouches partially air filled

Slide6

PROBLEM LIST

Bilateral Bulbar and Palpebral Conjunctival ThickeningThird Eyelid ProtrusionBilateral ExophthalmosMild Ocular DischargeGuttural pouches partially air filledTemperature DecreasedTachypnea

Slide7

DIFFERENTIAL DIAGNOSIS

Bilateral Bulbar/Palpebral Conjunctival ThickeningForeign Body NeoplasiaBlepharitisExophthalmosThird Eyelid ProtrusionTraumaNeoplasiaBlepharitisGuttural Pouch Empyema

Bilateral ExophthalmosNeoplasiaOrbital Cellulitis

TraumaMild Ocular DischargeNeoplasiaConjunctivitisExophthalmosTrauma

Slide8

DIFFERENTIAL DIAGNOSIS

Guttural pouches partially air filledTraumaNeoplasiaGuttural Pouch EmpyemaSlightly Decreased TemperatureCold StressPoor PerfusionTrauma

TachypneaStressPainPneumoniaNeoplasia

Slide9

DIAGNOSIS

Presumptive DiagnosisSevere, Bilateral Inflammation of Third Eyelid and Palpebral ConjunctivaPossible Mass in the Guttural Pouch Area

Slide10

TREATMENT PLAN

Palliative TherapyBilateral Surgical Removal of Third EyelidsEyelids were submitted for HistopathologyHome Treatment InstructionsAnalgesia/ Anti-inflammatoryPhenylbutazone (4.4mg/kg, PO, SID for 7 days, then 1-2 gram as needed to decrease swelling or discomfort)Topical antibiotic ointment NEOMYCIN/POLYMYXIN B/BACITRACIN ZINC EYE OINT 3.5 (BID until tube is empty)Clean discharge/blood from eyes with wet paper towel

Bloody discharge normal for 1-2 days post-op

Slide11

OUTCOME 1

“Hank” was discharged from hospital with Home Treatment InstructionsThird Eyelids were submitted for Histopathology

Slide12

HISTOPATHOLOGY RESULTS

Both third eyelids, lacrimal gland, and adjacent conjunctiva were effaced by an infiltrative, non-encapsulated, poorly demarcated neoplasm The neoplasm was composed of densely packed with a pleomorphic population of round cell sheets. Mitotic figures are 3-5 per 400X field.

Moderate Anisocytosis/Anisokaryosis.

Slide13

HISTOPATHOLOGY RESULTS

Neoplastic cells do not extend into the overlying, intact conjunctival epithelium. Neoplastic cells extend to many tissue margins.Microscopic Diagnosis Third Eyelid Conjunctival LymphomaImmunohistochemical staining was requested to identify cell lineage

Slide14

IMMUNOHISTOCHEMISTRY RESULTS

Results:Predominant population of cells were B-lymphocytes (CD79a-positive)Small number of scattered T-lymphocytes (CD-3-positive)DiagnosisB-cell lymphoma

CD79a-Positive Cells

(B-Cells)

Immunohistochemical Staining

CD79a Positive Cells

 Indicate B-Lymphocyte Lineage

CD-3 Positive Cells  Indicate T-Lymphocyte Lineage

Slide15

OUTCOME 2

12/29/12: “Hank” was readmitted to ISU Equine Surgery ServiceDecreased conditionWeight LossSwelling at site of third eyelid removalHistory12/14/12: Bilateral Third Eyelid RemovalBiopsy/Histopathology of Third EyelidsDx: B-Cell Lymphoma

Slide16

CLINICAL FINDINGS

Physical ExaminationBilateral lower eyelid/conjunctival swelling. Bilateral ocular discharge Poor dilation and inability to examine fundus of the Left Eye Solid vitreous face and posterior lens luxation of Right EyeSubmandibular Lymph Nodes enlargedMultiple movable, semi-firm masses at Thoracic Inlet/Pelvic Area - Not noted at previous examMild inspiratory stridor at rest

Parameter

Hank’s ValueReference IntervalTemperature (F0/C0

)

99.0/37.2

99.0-100.8/37.2-38.1

Heart Rate (beats/minute)

36

28-40

Respiratory Rate (breaths/minute)

16

10-14

Slide17

DIAGNOSTIC PLAN

Rectal ExamNo Abnormalities notedAbdominocentesisSlightly cloudyProtein = 2.2 g/dLNeurology ExamNo Abnormalities notedCBCSlight Anisocytosis of RBCNo other abnormalities noted

Endoscopy of Upper AirwayArytenoids obscured by ventral displacement of the roof of the pharynxPurulent material found in the Left Guttural Pouch Lateral Compartment.

Unable to enter Right Guttural Pouch due to Swelling/ScarringDue to worsening of clinical signs the owner elected for humane euthanasia and necropsy

Slide18

NECROPSY RESULTS-GROSS

Orbit ConjunctivaBilaterally Swollen approximately 3cm x 2cmRight Guttural Pouch200-mL of thick, white/yellow exudate Left Guttural PouchModerate amount of friable material. Multiple 1-10mm nodules caudal to pouchCranial Mediastinal Lymph Node

Enlarged and moderately firm. Diameter 10cm

Slide19

NECROPSY RESULTS-GROSS

Left Caudal Lung LobeWhite 7cm noduleOn cut surface, there were areas of concentric thickening around luminal structuresMesenteryPedunculated 10-15cm diameter white/yellow massMultiple non-pedunculated, white/yellow masses were also present.Gross Morphological Diagnoses

Multifocal LymphadenopathyGuttural Pouch Empyema

Slide20

NECROPSY RESULTS HISTOPATHOLOGY

Pituitary Gland (Pars Distalis & Pars Intermedia)Expanded by well-demarcated, non-encapsulated infiltrative neoplastic mass of densely packed round cell sheets High number of mitotic figures (28/10hpf) and abnormal nuclei & nucleoli changesLymph NodeDiffusely enlarged, with increased numbers of germinal centers; large lymphocytes expanding germinal centers

Lung Parenchyma, Palpebral Conjunctiva, Eye, & Adipose TissueTissues were expanded/effaced by Neoplastic Cells similar in morphology to those described in the Pituitary Gland

Slide21

NECROPSY RESULTS IMMUNOHISTOCHEMISTRY

Pituitary GlandScattered cells stained positively for T-Lymphocytes (CD-3) and for B-Lymphocytes (CD79a).Eyelid MassApproximately 90% of neoplastic cells were positive for B-Lymphocytes (CD79a) A few scattered cells were positive for T-Lymphocytes (CD-3)

CD-3 Positive (T-Lymphocyte)

CD79a Positive (B-Lymphocyte)

Slide22

FINAL DIAGNOSIS

T-Cell Rich B-Cell LymphomaGrave PrognosisMost horses die or are humanely euthanized within 6 months of clinical onsetCommon secondary tumor of palpebral conjunctivaOften associated with multicentric lymphoma

Slide23

T-CELL RICH B-CELL LYMPHOMA

Clinical SignsOften Related to loss of organ function from Lymphocyte Infiltration/Mass ObstructionAnorexia; Emaciation; Lymph Node Enlargement (~2/3 of Cases)

Ocular Manifestation of Multicentric LymphomaInfiltration of upper, lower and third eyelids, conjunctiva, orbit, and globe. Retinal Detachment. Common secondary tumor site for lymphoma

Slide24

T-CELL RICH B-CELL LYMPHOMA

Treatment OptionsLimitedTransient improvement in generalized formsCytotoxic drugs, immunomodulators, corticosteroidsLong term response is poorSurgical resection of tumorsSometimes curative or significantly prolong survival

Humane euthanasia

Slide25

FURTHER READING

Germann SE, Richter M, Schwarzwald CC, Wimmershoff J, Spiess BM. Ocular and multicentric lymphoma in a young racehorse. Vet Ophthalmol. Sep 2008;11 Suppl 1:51-56Meyer J, Delay J, Bienzle D. Clinical, laboratory, and histopathologic features of equine lymphoma. Vet Pathol. Nov 2006;43(6):914-924.Reed S, Bayly W, Sellon D. 

Equine Internal Medicine. 2nd ed: Saunders; 2004.Barnett K, Crispin S, Lavach J, Matthews A. Equine Ophthalmology.2nd ed: Saunders; 2004. Kelley LC, Mahaffey EA(1998). Equine Malignant Lymphomas: Morphologic

and Immunohistochemical Classification. Vet Pathol 35: 241

Slide26

ACKNOWLEDGEMENTS

MentorStephanie Caston, DVM, DACVS-LAPictures Provided ByElizabeth Whitley, DVM, PhD, DACVPR. David Whitley, DVM, MS, DACVOStephanie Caston, DVM, DACVS-LA

Kenneth Waller, DVM

PathologyElizabeth Whitely, DVM, PhD, DACVPJoseph S. Haynes, DVM, PhD, DACVPMolly D. Murphy, DVM, PhDRadiologyKenneth Waller, DVM